Evidence map›Paper›PMID 25755923›Full record

ArticlePeerJ2015

Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR.

Sarah Tavernier, Tom Coenye

Abstract read
In one paragraph

Article in PeerJ, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluation of novel compounds as anti-bacterial or anti-virulence agents.Frontiers in cellular and infection microbiology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Detection ofFrontiers in microbiology · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Activity of Antibiotics against Pseudomonas aeruginosa in anAntimicrobial agents and chemotherapy · 2020
    Article
  13. Article
  14. Article
  15. Activity of Antibiotics against Staphylococcus aureus in anAntimicrobial agents and chemotherapy · 2019
    Article
  16. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sarah TavernierLaboratory of Pharmaceutical Microbiology, Ghent University , Ghent , Belgium.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University , Ghent , Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multispecies biofilms are an important healthcare problem and may lead to persistent infections. These infections are difficult to treat, as cells in a biofilm are highly resistant to antimicrobial agents. While increasingly being recognized as important, the properties of multispecies biofilms remain poorly studied. In order to do so, the quantification of the individual species is needed. The current cultivation-based approaches can lead to an underestimation of the actual cell number and are time-consuming. In the present study we set up a culture-independent approach based on propidium monoazide qPCR (PMA-qPCR) to quantify Pseudomonas aeruginosa in a multispecies biofilm. As a proof of concept, we explored the influence of the combined presence of Staphylococcus aureus, Streptococcus anginosus and Burkholderia cenocepacia on the antimicrobial susceptibility of P. aeruginosa using this PMA-qPCR approach.

Indexed as

BiofilmPMA-qPCRPseudomonas aeruginosaResistance

Identifiers

PMID25755923
PMCPMC4349053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.